Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1,2-Dihexanoyl-sn-glycerol is a lipid molecule that plays a significant role in cellular signaling and function. It is derived from sn-glycerol, a simple polyol compound, and has two hexanoyl groups attached to its first and second carbon atoms. This molecule is known for its ability to act as a bioregulator of protein kinase C (PKC) in human platelets, which is crucial for various cellular processes.

30403-47-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 30403-47-5 Structure
  • Basic information

    1. Product Name: 1,2-DIHEXANOYL-SN-GLYCEROL
    2. Synonyms: 1,2-DIHEXANOYL-SN-GLYCEROL;1,2-DIHEXANOYL-SN-GLYCEROL (C6:0);1,2-DIHEXANOYL-SN-GLYCEROL (C6:3);glyceryl 1,2-dihexanoate
    3. CAS NO:30403-47-5
    4. Molecular Formula: C15H28O5
    5. Molecular Weight: 288.37982
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 30403-47-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1,2-DIHEXANOYL-SN-GLYCEROL(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1,2-DIHEXANOYL-SN-GLYCEROL(30403-47-5)
    11. EPA Substance Registry System: 1,2-DIHEXANOYL-SN-GLYCEROL(30403-47-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 30403-47-5(Hazardous Substances Data)

30403-47-5 Usage

Uses

Used in Pharmaceutical Industry:
1,2-Dihexanoyl-sn-glycerol is used as a bioregulator for protein kinase C (PKC) in human platelets. Its role in regulating PKC is essential for maintaining proper cellular function and signaling, which can have implications in the development of therapeutic strategies for various diseases and conditions.
Used in Research and Development:
1,2-Dihexanoyl-sn-glycerol is also utilized in research and development for studying the role of PKC in cellular processes. By understanding the interactions between this lipid molecule and PKC, researchers can gain insights into the underlying mechanisms of various diseases and potentially develop targeted treatments.
Used in Drug Delivery Systems:
Similar to gallotannin, 1,2-dihexanoyl-sn-glycerol can be incorporated into drug delivery systems to enhance its applications and efficacy. By using various organic and metallic nanoparticles as carriers, the delivery, bioavailability, and therapeutic outcomes of this molecule can be improved, potentially leading to more effective treatments for a range of conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 30403-47-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,4,0 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 30403-47:
(7*3)+(6*0)+(5*4)+(4*0)+(3*3)+(2*4)+(1*7)=65
65 % 10 = 5
So 30403-47-5 is a valid CAS Registry Number.

30403-47-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-decyl-3-hydroxypentanedioic acid

1.2 Other means of identification

Product number -
Other names 1,2-dihexanoyl-sn-glycerol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:30403-47-5 SDS

30403-47-5Downstream Products

30403-47-5Relevant articles and documents

Positional specificity and stereoselectivity of a lipase preparation from oat seeds acting on 1,2,3-trihexanoylglycerol

Ota, Yasuhide,Minesaki, Toshio,Oshima, Aki

, p. 166 - 167 (1997)

Oat seed lipase was extracted with 0.01 M calcium chloride solution containing 0.5% Triton X-100 and precipitated with ammonium sulfate. The precipitate was dissolved in phosphate buffer at pH 6.0 and the supernatant was used as the lipase preparation. The lipase was very selective in the ester positions of 1,2-trihexanoylglycerol, hydrolyzing sn-3 most quickly, sn-1 moderately, and sn-2 hardly at all.

Synthesis and biological evaluation of phosphatidylinositol phosphate affinity probes

Conway, Stuart J.,Gardiner, James,Grove, Simon J. A.,Johns, Melloney K.,Lim, Ze-Yi,Painter, Gavin F.,Robinson, Diane E. J. E.,Schieber, Christine,Thuring, Jan W.,Wong, Leon S.-M.,Yin, Meng-Xin,Burgess, Antony W.,Catimel, Bruno,Hawkins, Phillip T.,Ktistakis, Nicholas T.,Stephens, Leonard R.,Holmes, Andrew B.

supporting information; experimental part, p. 66 - 76 (2010/04/29)

The synthesis of the complete family of phosphatidylinositol phosphate analogues (PIPs) from five key core intermediates A-E is described. These core compounds were obtained from myo-inositol orthoformate 1 via regioselective DIBAL-H and trimethylaluminium-mediated cleavages and a resolution-protection process using camphor acetals 10. Coupling of cores A-E with phosphoramidites 34 and 38, derived from the requisite protected lipid side chains, afforded the fully-protected PIPs. Removal of the remaining protecting groups was achieved via hydrogenolysis using palladium black or palladium hydroxide on carbon in the presence of sodium bicarbonate to afford the complete family of dipalmitoyl- and amino-PIP analogues 42, 45, 50, 51, 58, 59, 67, 68, 76, 77, 82, 83, 92, 93, 99 and 100. Investigations using affinity probes incorporating these compounds have identified novel proteins involved in the PI3K intracellular signalling network and have allowed a comprehensive proteomic analysis of phosphoinositide interacting proteins. The Royal Society of Chemistry 2010.

Synthetic approaches to heavily lipidated phosphoglyceroinositides

Schlueter, Urs,Lu, Jun,Fraser-Reid, Bert

, p. 255 - 257 (2007/10/03)

(Matrix presented) Naturally occurring phosphoinositide glycoconjugates are equipped with varied acyl residues that are important for their biological activity and biosynthesis. This paper reports that acylation at O2 of the myo-inositol moiety can be ach

Cosmetic composition

-

, (2008/06/13)

A composition suitable for topical application to mammalian skin and hair for inducing, maintaining or increasing hair growth comprises a hair growth promoter chosen from glutamine derivatives and salts thereof. The composition preferably also comprises an activity enhancer which may be chosen from hair growth stimulants, penetration enhancers and cationic polymers.

Cosmetic composition containing DOPA derivatives

-

, (2008/06/13)

A composition for topical application to human hair or skin contains a chemical analogue of dihydroxyphenyl alanine (DOPA). This chemical analogue can be absorbed by skin or by a hair follicle and metabolised in-vivo, thus leading to the formation of melanin in skin or to the growth of melanin-pigmented hair. Consequently the composition can give controlled skin darkening to mimic sun-induced tanning or can bring about the growth of dar hair in place of the grey or white hair.

General Method for the Synthesis of Phospholipid Derivatives of 1,2-O-Diacyl-sn-glycerols

Martin, Stephen F.,Josey, John A.,Wong, Yue-Ling,Dean, Daniel W.

, p. 4805 - 4820 (2007/10/02)

An efficient phosphite coupling protocol is described for the syntheses of the major classes of phospholipids that are derived from 1,2-O-diacyl-sn-glycerols and analogues thereof.The symmetrical diacyl glycerols 10c,d were prepared by straightforward acylation of 3-O-benzyl-sn-glycerol (7) with the appropriate carboxylic acid in the presence of dicyclohexylcarbodiimide (DCC) and 4-(dimethylamino)pyridine (DMAP).A simple method for preparing saturated and unstaturated mixed 1,2-O-diacyl-sn-glycerols was then devised that involved stepwise acylation of 7 with different alkyl carboxylic acids and debenzylation; this procedure is exemplified by the preparation of 10a,b.The 1,2-O-diacyl-sn-glycerols 10a-d were then coupled with suitably protected lipid head groups employing reactive alkyl or aryl dichlorophosphites to give intermediate phosphite triesters in high overall yields.Oxidation or sulfurization of these phosphites proceeded smoothly to give the corresponding phosphate or phosphorothioate triesters, deprotection of which then provided the phosphatidylcholines 16 and 17, the phosphatidylethanolamine 20, the phosphatidylserine 28, and the phosphatidylinositols 37 and 38.Preparation of 37 and 38 required the invention of an improved method for resolving the isopropylidene-protected D-myo-inositol derivative 33.This phosphite coupling procedure was modified to assemble phospholipids bearing polyunsaturated acyl side chains at the sn-2-position as exemplified by the preparation of the phosphatidylethanolamine 26.The one-pot phosphite coupling procedure is also applicable to the syntheses of a variety of other biologically interesting phospholipid analogues.For example, the phosphatidylinositol analogues 49-51, in which the hydroxyl group at C(2) of the inositol ring has been modified, were prepared in excellent overall yields by conjoining the 1,2-O-diacyl-sn-glycerol 10c with the protected inositol derivatives 44, 45, and 48.Phospholipid analogues that contain other replacements of the phosphate group including phosphoramidates and thiophosphates may be prepared as evidenced by the syntheses of 56 and 61 in which the sn-3 oxygen atom of the 1,2-O-diacyl-sn-glycerol moiety is replaced with an N-benzyl group or a sulfur atom, respectively.

Substrate specificity in short-chain phospholipid analogs at the active site of human synovial phospholipase A2

Wheeler,Blanchard,Andrews,Fang,Gray-Nunez,Harris,Lambert,Mehrotra,Parks,Ray,Smalley Jr.

, p. 4118 - 4129 (2007/10/02)

The substrate specificity at the active site of recombinant human synovial fluid phospholipase A2 (hs-PLA2) was investigated by the preparation of a series of short-chain phospholipid analogs and measurement of their enzymatic hydrolysis at concentrations well below the critical micelle concentration. Substrates used in the study included 1,2-dihexanoylglycerophospholipids, 1,2-bis(alkanoylthio)glycerophospholipids, and 1-O-alkyl-2- (alkanoylthio)phospholipids. Turnover was observed for only a few of the 1,2- dihexanoylglycerophospholipids, and the rate of hydrolysis was very low, near the limit of detection of the assay. In contrast, selected 2-(alkanoylthio)- glycerophospholipids were hydrolyzed by hs-PLA2 at much higher rates at concentrations well below their critical micelle concentration (cmc). Thus, the 1,2-bis(hexanoylthio)glycerophosphatidylmethanol exhibits a k(cat)/K(M) = 1800 L mol-1 s-1. Over the calculated log P (cLogP) range of 3-9, cLogP and log(k(cat)/K(M)) were linearly related for compounds with straight-chain sn-1 and sn-2 substituents. At comparable cLogP's, the sn-1 ethers and thioesters were hydrolyzed at comparable rates. A negative charge in the phosphate head group was required for enzyme activity. Unsaturation, aromaticity, and branching in the sn-2 substituent reduce turnover dramatically. The same structural modifications in the sn-1 substituent have less effect on turnover. Certain of these substrates, e.g., 1,2- bis(hexanoylthio)glycerophosphatidylmethanol, may be useful in assaying for active site inhibitors of PLA2. The structure-activity relationships established here for substrates should serve as a reference for the structure-activity relationships of substrate-based inhibitors.

Cosmetic composition

-

, (2008/06/13)

A composition suitable for topical application to mammalian skin or hair for inducing, maintaining or increasing hair growth comprises a glycosaminoglycanase inhibitor chosen from aldonomonolactones, alduronomonolactones and acylated monosaccharides, and a cosmetically acceptable vehicle for the inhibitor; the total amount of the inhibitor present in the composition being sufficient to increase hair growth in the rat, when said composition is applied topically thereto over a period of no more than 3 months, by at least 10% more than that obtainable using a control composition from which the said inhibitor has been omitted, in accordance with the Rat Hair Growth Test.

Cosmestic composition

-

, (2008/06/13)

A composition suitable for topical application to mammalian skin and hair for inducing, maintaining or increasing hair growth comprises a hair growth promoter chosen from glutamic acid derivatives and salts thereof. The composition preferably also comprises an activity enhancer which may be chosen from hair growth stimulants, penetration enhancers and cationic polymers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 30403-47-5